Articles by Daniel Marsh
Nebius Plunges 11% on $4.5B Convertible Note Sale
Nebius shares dropped 10.8% after a $4.5B convertible note offering, covering 80% of quarterly AI infrastructure spend. Analysts see 24% upside.
Nike Bounces 2.5% Off 12-Year Low, But Analysts Remain Cautious
Nike shares recovered 2.5% on Tuesday after hitting a 12-year low, but Wall Street remains cautious with a Hold consensus and a price target 26% above the current price.
SK Hynix Unveils Record $29B Buyback After 9.8% Stock Slide
SK Hynix launches a 40 trillion won buyback and cancellation, its largest ever, after shares fell 9.8%. The plan uses 57.6% of net cash and targets 3.3% of outstanding shares.
Transocean Stock Lags Oil Rally Amid $6.7B Backlog and $5.1B Debt
Transocean (RIG) shares slipped 0.85% to $5.82 even as Brent crude climbed to $91.56. The company's $6.7B backlog exceeds its $5.1B debt, but operational challenges and merger risks weigh on investor sentiment.
ASML Outshines Rivals as Bond Yields Climb
ASML shares gained 0.4% amid a bond market selloff, as the company targets a 38-49% second-half sales surge. Analysts remain bullish, but buyback prices loom overhead.
Hyundai Stock Slips 4.8% as Tucson Redesign Faces Margin Test
Hyundai shares dropped 4.8% after unveiling the new Tucson, which made up 23.9% of U.S. sales in July. The redesign could pressure margins as Q2 operating profit fell 20.8%.
Cipher Digital Stock Plunges 13%, Market Cap Drops $1B
Cipher Digital shares tumbled 13% on Tuesday, wiping out $1 billion in market value amid rising bond yields and investor scrutiny of its $11.4 billion backlog.
CME Hits 4-Year High as FX Hedging Demand Jumps, But Rates Still Dominate
CME shares climbed to a four-year high as a survey shows record FX hedging, but currency futures are just 3% of volume. Rates and equities still drive the mix.
FreeCast Shares Skyrocket 144% on Record Volume, Yet No Fresh Catalysts Emerge
FreeCast (CAST) jumped 144% to $2.10 on 127.7 million shares, 11x its average volume. No new disclosures accompanied the surge, leaving traders to speculate on the catalyst.
SK Hynix's $28.6B Buyback, Carlsberg's Outlook, and Valero's Record High
SK Hynix announces $28.6B buyback, Carlsberg lifts 2026 outlook, Valero nears record on diesel margins, and Lyntris IPO prices below range.
Novo Nordisk Gains 1.9% as Medicare Wegovy Copay Trial Raises Pricing Questions
Novo Nordisk's ADR gained 1.85% to $45.71 as Medicare's GLP-1 Bridge offers Wegovy at $50 monthly, but analysts see limited upside with all Holds.